Flexor digitorum profundus tendon infiltration by post-traumatic hemangioma. A pediatric case.

Auteurs : Raei A, Antoniou G, Gkotsi A, de Saint Aubain N, El Kazzi W
Jaar : 2022
Journal : Hand Surg Rehabil
Volume : 41
Pagina's : 520-522

Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma.

Auteurs : Pinjusic K, Dubey OA, Egorova O, Nassiri S, Meylan E, Faget J, Constam DB
Jaar : 2022
Journal : J Immunother Cancer
Volume : 10

Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform.

Auteurs : Morfouace M, Novello S, Stevovic A, Dooms C, Berghmans T, Dziadziuszko R, Gorlia T, Felip E, Paz-Ares L, Mazieres J, OBrien M, Bironzo P, Vansteenkiste J, Lacroix L, Dingemans AC, Golfinopoulos V, Besse B
Jaar : 2022
Journal : Sci Rep
Volume : 12
Pagina's : 8342

First-in-man, first-in-class phase I study with the monopolar spindle 1 kinase inhibitor S81694 administered intravenously in adult patients with advanced, metastatic solid tumours.

Auteurs : Schöffski P, Awada A, de la Bigne AM, Felloussi Z, Burbridge M, Cantero F, Colombo R, Maruzzelli S, Ammattatelli K, de Jonge M, Aftimos P, Dumez H, Sleijfer S
Jaar : 2022
Journal : Eur J Cancer
Volume : 169
Pagina's : 135-145

Oligorecurrent nodal prostate cancer: radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial.

Auteurs : Achard V, Jaccard M, Vanhoutte F, Siva S, Heikkilä R, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Berghen C, Shelan M, Conde-Moreno A, Campos FL, Papachristofilou A, Guckenberger M, Meersschout S, Putora PM, Zwahlen D, Couñago F, Scorsetti M, Eito C, Barrado M, Zapatero A, Muto P, Van De Voorde L, Lamanna G, Koutsouvelis N, Dipasquale G, Ost P, Zilli T
Jaar : 2022
Journal : Radiother Oncol

Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study.

Auteurs : Subbiah V, Braña I, Longhi A, Boni V, Delord JP, Awada A, Boudou-Rouquette P, Sarantopoulos J, Shapiro GI, Elias A, Ratan R, Fernandez C, Kahatt C, Cullell-Young M, Siguero M, Zeaiter A, Chawla SP
Jaar : 2022
Journal : Clin Cancer Res
Volume : 28
Pagina's : 2762-2770

Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the My Personal Breast Screening" (MyPeBS) randomised clinical trial."

Auteurs : Roux A, Cholerton R, Sicsic J, Moumjid N, French DP, Giorgi Rossi P, Balleyguier C, Guindy M, Gilbert FJ, Burrion JB, Castells X, Ritchie D, Keatley D, Baron C, Delaloge S, de Montgolfier S
Jaar : 2022
Journal : BMC Cancer
Volume : 22
Pagina's : 507

Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy.

Auteurs : Lambertini M, Fielding S, Loibl S, Janni W, Clark E, Franzoi MA, Fumagalli D, Caballero C, Arecco L, Salomoni S, Ponde NF, Poggio F, Kim HJ, Villarreal-Garza C, Pagani O, Paluch-Shimon S, Ballestrero A, Del Mastro L, Piccart M, Bines J, Partridge AH, de Azambuja E
Jaar : 2022
Journal : J Natl Cancer Inst
Volume : 114
Pagina's : 1117-1126

Erratum to Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust": [Annals of Oncology 32 (2021) 1077-1082]."

Auteurs : Piccart MJ, Kalinsky K, Gray R, Barlow WE, Poncet C, Cardoso F, Winer E, Sparano J
Jaar : 2022
Journal : Ann Oncol
Volume : 33
Pagina's : 668

Neutrophil phenotypes and functions in cancer: A consensus statement.

Auteurs : Quail DF, Amulic B, Aziz M, Barnes BJ, Eruslanov E, Fridlender ZG, Goodridge HS, Granot Z, Hidalgo A, Huttenlocher A, Kaplan MJ, Malanchi I, Merghoub T, Meylan E, Mittal V, Pittet MJ, Rubio-Ponce A, Udalova IA, van den Berg TK, Wagner DD, Wang P, Zychlinsky A, de Visser KE, Egeblad M, Kubes P
Jaar : 2022
Journal : J Exp Med
Volume : 219

T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy.

Auteurs : Garaud S, Dieu-Nosjean MC, Willard-Gallo K
Jaar : 2022
Journal : Nat Commun
Volume : 13
Pagina's : 2259

MONARCH-plus: the evidence of efficacy and safety of abemaciclib in countries with limited clinical research opportunitie

Auteurs : Awada A, Gombos A
Jaar : 2022
Journal : TBCR
Volume : -
Pagina's : 4 pages

Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study.

Auteurs : Pérez-García JM, Gebhart G, Borrego MR, Schmid P, Marmé F, Prat A, Dalenc F, Kerrou K, Colleoni M, Braga S, Malfettone A, Sampayo-Cordero M, Cortés J, Llombart-Cussac A
Jaar : 2022
Journal : Future Oncol
Volume : 18
Pagina's : 3677-3688

HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study.

Auteurs : Gilles C, Rozenberg S, Buxant F, Manigart Y, de Wind R, Houte KV, Vandenbroeck D, Delforge M, Konopnicki D
Jaar : 2022
Journal : Vaccine
Volume : 40
Pagina's : 7230-7237

Line-field confocal optical coherence tomography: a new tool for non-invasive differential diagnosis of pustular skin disorders.

Auteurs : Tognetti L, Cinotti E, Falcinelli F, Miracco C, Suppa M, Perrot JL, Rubegni P
Jaar : 2022
Journal : J Eur Acad Dermatol Venereol
Volume : 36
Pagina's : 1873-1883

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit.

Auteurs : Oosting SF, Barriuso J, Bottomley A, Galotti M, Gyawali B, Kiesewetter B, Latino NJ, Martinelli F, Pe M, Pentheroudakis G, Roitberg F, Vachon H, de Vries EGE, Piccart-Gebhart M, Cherny NI
Jaar : 2022
Journal : Ann Oncol

Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancer.

Auteurs : Awada AH, Boni V, Moreno V, Aftimos P, Kahatt C, Luepke-Estefan XE, Siguero M, Fernandez-Teruel C, Cullell-Young M, Tabernero J
Jaar : 2022
Journal : ESMO Open
Volume : 7
Pagina's : 100651

Improving Infinium MethylationEPIC data processing: re-annotation of enhancers and long noncoding RNA genes and benchmarking of normalization methods.

Auteurs : Bizet M, Defrance M, Calonne E, Bontempi G, Sotiriou C, Fuks F, Jeschke J
Jaar : 2022
Journal : Epigenetics
Volume : 17
Pagina's : 2434-2454

Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic Activity.

Auteurs : Berretta M, Dal Lago L, Tinazzi M, Ronchi A, La Rocca G, Montella L, Di Francia R, Facchini BA, Bignucolo A, Montopoli M
Jaar : 2022
Journal : Cancers (Basel)
Volume : 14

Intraoperative electron radiotherapy in early invasive ductal breast cancer: 6-year median follow-up results of a prospective monocentric registry.

Auteurs : Philippson C, Larsen S, Simon S, Vandekerkhove C, De Caluwe A, Van Gestel D, Chintinne M, Veys I, De Neubourg F, Noterman D, Roman M, Nogaret JM, Desmet A
Jaar : 2022
Journal : Breast Cancer Res
Volume : 24
Pagina's : 83